Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
In China, beyond the in-market products such as semaglutide and tirzepatide and promising global pipeline assets including orforglipron (oral), MariTide (monthly injectable) and retatrutide (triple agonist), a range of China-only molecules is also emerging with strong competitiveness (see Table 2)
Discuss your history, goals, and treatment options
The mechanism behind GLP-1 (glucagon-like peptide-1) involves its role in regulating blood sugar levels, insulin secretion, and appetite control
PMID 18272931
Want to see how the options stack up
US$ 25.03
US$ 21.98
US$ 21.92
US$ 24.76
